BlackRock
ANVS icon

BlackRock’s Annovis Bio ANVS Stock Holding History

BlackRock’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
249,856
+110,323
+79% +$215K ﹤0.01% 4596
2026
Q1 		$311K Hold
139,533
– – ﹤0.01% 4640
2025
Q4 		$483K Buy
139,533
+58,858
+73% +$177K ﹤0.01% 4494
2025
Q3 		$167K Hold
80,675
– – ﹤0.01% 4717
2025
Q2 		$175K Sell
80,675
-19,954
-20% -$39.4K ﹤0.01% 4701
2025
Q1 		$151K Sell
100,629
-11,350
-10% -$34.7K ﹤0.01% 4660
2024
Q4 		$563K Buy
111,979
+10,484
+10% +$75.9K ﹤0.01% 4378
2024
Q3 		$818K Buy
101,495
+786
+0.8% +$7.37K ﹤0.01% 4221
2024
Q2 		$580K Buy
100,709
+3,080
+3% +$25K ﹤0.01% 4307
2024
Q1 		$1.16M Buy
97,629
+1,645
+2% +$17.9K ﹤0.01% 4161
2023
Q4 		$1.79M Sell
95,984
-297
-0.3% -$2.63K ﹤0.01% 4078
2023
Q3 		$914K Sell
96,281
-1,012
-1% -$12.5K ﹤0.01% 4276
2023
Q2 		$1.39M Buy
97,293
+3,047
+3% +$43.1K ﹤0.01% 4192
2023
Q1 		$1.45M Sell
94,246
-8,950
-9% -$145K ﹤0.01% 4197
2022
Q4 		$1.39M Sell
103,196
-41,253
-29% -$516K ﹤0.01% 4291
2022
Q3 		$1.98M Sell
144,449
-2,363
-2% -$31.1K ﹤0.01% 4202
2022
Q2 		$1.66M Sell
146,812
-881
-0.6% -$9.63K ﹤0.01% 4324
2022
Q1 		$1.97M Buy
147,693
+94
+0.1% +$1.36K ﹤0.01% 4404
2021
Q4 		$2.6M Buy
147,599
+44,269
+43% +$1.14M ﹤0.01% 4300
2021
Q3 		$3.28M Buy
103,330
+2,333
+2% +$134K ﹤0.01% 4116
2021
Q2 		$8.64M Buy
+100,997
New +$4.67M ﹤0.01% 3694

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock's ANVS Position: Q2 2026 in Review

BlackRock increased its Annovis Bio (ANVS) stake by 79% in Q2 2026, buying an estimated $215K and bringing the position to 249,856 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #4596.

BlackRock first reported a position in ANVS in Q2 2021 and has held it in 21 quarters since. The position peaked at $8.64M in Q2 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • BlackRock held 249,856 shares of Annovis Bio worth $465K as of Q2 2026.
  • BlackRock bought 110,323 Annovis Bio shares in Q2 2026, an estimated $215K.
  • Annovis Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4596 holding.
  • BlackRock first reported a position in Annovis Bio in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's Annovis Bio position peaked at $8.64M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.